Announcing the 2026 VC-Founder Physical AI Matchup, with meetings taking place online between May 11th (Monday) and May 15th (Friday). This virtual event will bring together 250+ startups and 250+ investors for 1:1 meetings online, scheduled at mutually convenient times. In 2025, SOSV Matchups generated over 6,500 one-on-one meetings in categories that included Health Tech, […]

SOSV portfolio company unspun is taking a bold step toward reshaping how clothes are made in the U.S. The company, known for its near-zero-waste weaving technology, is planning to raise $40 million in project-level financing to build 10 factories across the U.S. These facilities will use AI-enabled 3D weaving machines designed to produce garments closer […]

SOSV portfolio company HexemBio recently spoke with Axios following its new $10.4 million Seed funding led by Draper Associates, with participation from SOSV, Seraphim, and others. The company is tackling a core driver of aging: the decline of blood stem cells that power the immune system. While past approaches (gene editing, chemical treatments, or transcription-factor reprogramming) often introduce instability […]

SOSV portfolio company Metabolic Psychiatry Labs is helping redefine how we understand mental health. Founder and CEO Dr. Shebani Sethi, a Stanford University researcher, studies the role of metabolic dysfunction in conditions like depression, schizophrenia, and other disorders. This week, she published a new peer-reviewed paper in Nature Mental Health and spoke to STAT News […]

SOSV portfolio company Aspect Aerospace recently spoke with SpaceNews about two major milestones: a $1.9 million Direct-to-Phase II (D2P2) SBIR award from the U.S. Space Force and a $500,000 pre-seed investment from SOSV. Aspect Aerospace is rethinking how spacecraft are designed and deployed with its Single-Board Satellite (SBS). Instead of launching one conventional spacecraft, Aspect […]

For years, the biotech industry has poured billions into targeting epigenetic disease, only to run into the same wall. Most drugs go after catalytic pockets on enzymes. But those targets often exist in both healthy and diseased cells, making it incredibly difficult to achieve precision without unintended side effects. That’s where SOSV portfolio company TippingPoint […]

Recognized “for creating a soil-powered battery for precision-ag sensors”, SOSV portfolio company Bactery was named to Fast Company’s list of Most Innovative Companies of 2026! Bacteries are batteries powered by bacteria. The rise of precision ag has put roughly a quarter billion sensors on farms worldwide, most of them depending on single-use batteries or complex […]

SOSV portfolio company Cauldron talked to TechCrunch about their $13.25 million Series A2 round, led by Main Sequence Ventures with participation from Horizons Ventures, NGS Super, and SOSV. 60% of inputs to the global economy could be produced biologically. Cauldron is making that future tangible. Their “hyper fermentation” technology keeps microbes in a continuously optimized, […]

This year, five SOSV portfolio companies were named to Fast Company’s Most Innovative Companies of 2026 List! Cauldron Ferm For lowering the costs of industrial-scale biomanufacturing Cauldron Ferm is an Australia-based biomanufacturing company that aims to transform the way everyday goods are made using precision fermentation. That technique has been used for decades in pharmaceutical […]

Concrete is the most widely used material on earth after water, and we’re running out of a key ingredient. Widely used cement substitutes, known as supplementary cementitious materials (SCMs), have historically come from heavily polluting coal plants and iron blast furnaces. As those industrial processes are retired across the U.S. and Europe, SCM supply is […]